Dendritic cells: tools and targets for antitumor vaccination.
about
Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice.Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.The role of the e3 ligase cbl-B in murine dendritic cells.Bee Venom Phospholipase A2, a Good "Chauffeur" for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1.A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivoHigh-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors.A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma.Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanomaTargeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.Dendritic cells: a critical player in cancer therapy?Personalized dendritic cell-based tumor immunotherapy.Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy.Modulation of Immune Cell Functions by the E3 Ligase Cbl-b.The roles of leptin and adiponectin at the fetal-maternal interface in humans.A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.Potential applications for plasmacytoid dendritic cells in cancer immunotherapy.Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell Maturation.Immunotherapy of hepatocellular carcinoma
P2860
Q33519555-F79D4A58-B017-41A0-BD51-74C224194353Q34044908-ECAAC1CC-2B6C-41DE-80B6-266DEA0B1548Q34769671-E55F5B5F-D2D2-4A52-BED9-1F41839F220AQ34795079-44E815A9-1F47-45C9-8DB1-5B0D5D2B97E2Q35005484-8548A84D-FE36-4E82-8EAA-206C78255591Q35973549-32E34FE2-A576-4986-944C-41F6254F93B1Q36432130-1001E0D6-BD99-4878-AB7B-818921ED5643Q37096944-AF83BEEA-CCCA-44AB-90BE-C3139591FACBQ37144023-E1E524F4-2AAA-43BE-9884-D431FAD513E9Q37276138-E73ECAD9-B246-41EB-ABFA-69C344AA664FQ37693733-7C399F85-0121-49DF-A46D-F028AA48DC81Q38206571-EEBAB277-C8D4-4864-BC6C-DF7D85CC1BC8Q38393275-CAE92A31-8EDE-401C-AD32-6BD7113DCAA0Q38618349-6BCBCB9D-CE6E-481A-81FA-ABE91106E0F2Q39922106-07C795CE-4A17-4E30-AD8A-28521491DD8FQ48356056-EDAFE61D-99DD-4E5A-8E2B-7CF6BD9B5EA2Q51050849-A3156756-3106-4762-9B1E-0D7815F38DFDQ56896669-E1820A7E-93A0-4915-BB4F-5BB273DEA997
P2860
Dendritic cells: tools and targets for antitumor vaccination.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Dendritic cells: tools and targets for antitumor vaccination.
@ast
Dendritic cells: tools and targets for antitumor vaccination.
@en
type
label
Dendritic cells: tools and targets for antitumor vaccination.
@ast
Dendritic cells: tools and targets for antitumor vaccination.
@en
prefLabel
Dendritic cells: tools and targets for antitumor vaccination.
@ast
Dendritic cells: tools and targets for antitumor vaccination.
@en
P2093
P2860
P356
P1476
Dendritic cells: tools and targets for antitumor vaccination.
@en
P2093
Gosse J Adema
Martijn H M G M den Brok
Theo J M Ruers
P2860
P304
P356
10.1586/14760584.4.5.699
P577
2005-10-01T00:00:00Z